Increased systemic sC5b-9 and C5a levels have been described in patients admitted to intensive care, while here we show that systemic complement activation is present in the majority of COVID-19 patients admitted to hospital and, importantly, this activation was associated with the presence of respiratory failure at admission or evolvement during hospitalization (11). The gene discussed is C5; the disease is respiratory failure.